Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zynerba Pharma CS (ZYNE)

Zynerba Pharma CS (ZYNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zynerba Pharma CS 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 USA

P: 484-581-7505

Description:

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 148,003
Shares Outstanding, K 23,198
Annual Sales, $ 90 K
Annual Net Income, $ -39,910 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,950 K
60-Month Beta 4.74
% of Insider Shareholders 10.79%
% of Institutional Shareholders 38.96%
Float, K 20,695
% Float 89.21%

Growth:

1-Year Return 35.61%
3-Year Return -53.35%
5-Year Return 0.00%
5-Year Revenue Growth -90.43%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/14/19
Earnings Per Share ttm -1.49
EPS Growth vs. Prev Qtr 84.00%
EPS Growth vs. Prev Year 82.98%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

ZYNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.50
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -40.53
Return-on-Assets (Before Tax) -36.09
Profit Margin % -44,344.44
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 1,664.32
Price/Cash Flow N/A
Price/Book 1.67
Book Value/Share 3.66
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar